基于液质联用及数据分析的血尿代谢组学在胆汁淤积症中的临床应用
何惠 1,丁向春 2 *,雒夏 2
作者信息
- 1 宁夏医科大学第一临床医学院 宁夏 银川 750004
- 2 宁夏医科大学总医院 宁夏 银川 750004
摘要
目的:基于超高效液相色谱-串联质谱技术联合生物信息学分析,分析胆汁淤积症患者血尿代谢物特征的差异性。方法:选取2024年1月至2025年12月于宁夏医科大学总医院收治的40例胆汁淤积症患者作为观察组,同时选择同期的40例健康体检者作为对照组。采用液质联用技术检测代谢谱,结合多种生物信息学方法筛选组间差异代谢物,并分析其关键代谢通路。结果:两组样本通过液质联用共检出有效代谢物627种;共筛选出显著差异代谢物78种,其中上调45种、下调33种;筛选出10个核心潜在生物标志物。结论:基于液质联用的血尿代谢组学能够对胆汁淤积症特征性的代谢紊乱情况进行精准识别,但其临床泛化能力尚需独立外部验证队列进一步评估。
Clinical Application of Blood and Urine Metabolomics Based on LC-MS and Data Analysis in Cholestasis
Hui He 1, Xiangchun Ding 2 *, Xia Luo 2
Author Information
- 1 School of Clinical Medicine, Ningxia Medical University, Yinchuan 750004, Ningxia Hui Autonomous Region, China
- 2 General Hospital of Ningxia Medical University, Yinchuan 750004, Ningxia Hui Autonomous Region, China
Abstract
Objective: To analyze the differences in blood and urine metabolite characteristics of patients with cholestasis based on ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) combined with bioinformatics analysis. Methods: A total of 40 patients with cholestasis admitted to the General Hospital of Ningxia Medical University from January 2024 to December 2025 were selected as the observation group, and 40 healthy physical examinees during the same period were selected as the control group. Metabolomic profiles were detected by LC-MS, and differentially expressed metabolites between the two groups were screened by multiple bioinformatics methods, followed by analysis of their key metabolic pathways. Results: A total of 627 valid metabolites were detected by LC-MS in the two groups; 78 significantly differential metabolites were screened out, including 45 upregulated and 33 downregulated; and 10 core potential biomarkers were identified. Conclusion: Blood and urine metabolomics based on LC-MS can accurately identify the characteristic metabolic disorders of cholestasis, but its clinical generalizability still needs to be further evaluated in an independent external validation cohort.
